Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Gastroenterology|August 10, 2001
Cost-effectiveness of interferon alfa-2b with and without ribavirin as therapy for chronic hepatitis C in SwedenK Sennfält, O Reichard, R Hultkrantz, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Prevention of hepatitis B by immunization of the newborn infant--a long-term follow-up study in Stockholm, SwedenP Sangfelt, O Reichard, K Lidman, et al.
Journal of Hepatology|June 12, 1999
Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferonO Reichard, H Glaumann, A Frydén, et al.
Lancet (London, England)|January 24, 1998
Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study GroupO Reichard, G Norkrans, A Frydén, et al.
Scandinavian Journal of Infectious Diseases|August 14, 1999
Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis CO Weiland, J H Braconier, A Frydén, et al.
Scandinavian Journal of Infectious Diseases|March 5, 1999
Comparison of 3 quantitative HCV RNA assays--accuracy of baseline viral load to predict treatment outcome in chronic hepatitis CO Reichard, G Norkrans, A Frydén, et al.
Acta Paediatrica (Oslo, Norway : 1992)|February 1, 1997
Interferon-alpha 2b treatment in hepatitis B carriers. Effect on hepatitis B virus DNA levels in children infected with different genotypesP Sangfelt, H Norder, L O Magnius, et al.
Journal of Viral Hepatitis|December 15, 2000
HCV RNA levels during therapy with amantadine in addition to interferon and ribavirin in chronic hepatitis C patients with previous nonresponse or response/relapse to interferon and ribavirinT Carlsson, K Lindahl, R Schvarcz, et al.
Liver|August 1, 1994
Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment courseO Reichard, H Glaumann, G Norkrans, et al.
Journal of Viral Hepatitis|August 20, 2005
Hepatitis C virus RNA kinetics during the initial 12 weeks treatment with pegylated interferon-alpha 2a and ribavirin according to virological responseT Carlsson, O Reichard, G Norkrans, et al.
Pageof 3